About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...

Brisbane-based ObvioHealth has signed a three-year agreement with clinical-stage biotechnology company Vaxxas to support late-stage trials.

Artificial intelligence threatens students’ most basic skills. If they lose their ability to understand what they read, will they lose their ability to think? By Anastasia Berg A.I. companies need to ...

One of the most pernicious conditions that afflicts around five million people worldwide is “geographic atrophy,” or GA, an advanced form of dry age-related macular degeneration that is one of the ...

Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic ...

Thermo Fisher Scientific (TMO) just posted third-quarter results that came in ahead of expectations, showing healthy revenue ...

Good drugs are potent and specific; that is, they must have strong effects on a specific biological pathway and minimal effects on all other pathways. Confirmation that a compound inhibits the ...

Food industry consultant Linda Eatherton shares her perspective on the critical steps food companies must take to ensure that they maintain—or regain—consumer trust.

Before receiving the implant, it was like having two black discs in my eyes, with the outside distorted,” said Sheila Irvine, ...

McGill Genome Centre, McGill University, Montreal, Quebec H3A 0G1, Canada Department of Biomedical Engineering, McGill University, Montreal, Quebec H3A 2B4, Canada McGill Genome Centre, McGill ...

Most pharmaceuticals sold today have their origin in a biochemistry laboratory. Drug discovery has traditionally started with a biochemical pathway implicated in a pathophysiological process. An ...